Where does Aposense Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aposense Ltd ranks #28,096 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aposense Ltd hold?

Aposense Ltd holds 9 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Aposense Ltd's Innovation Score?

Aposense Ltd has an Innovation Score of 50.7 out of 100 (top 13% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Aposense Ltd focus on?

Aposense Ltd's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 8 patents, ranking #2,696 of 7,163 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Aposense Ltd's patent grant rate increasing or decreasing?

Aposense Ltd's recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Aposense Ltd's patents?

Aposense Ltd's patents average 18.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aposense Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Aposense Ltd

USPTO PatentsView assignee record - 9 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aposense ranks #28,096 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 11 technology areas.

#28,096
of 49,997 US assignees by volume: Top 13%
by Innovation Score (50.7/100): 18.3
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R28096 · Foreign Corporation #28,096 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #28,096/49,997
PHOTO-FINISH AOK Innovations
CPC-FOCUS A61K · 11 areas
INNOV-PAR 50.7/100
CLAIMS-RICH 18.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: AOK Innovations, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aposense’s 50.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (16%) Velocity 20.0 pts (39%) Breadth 11.7 pts (23%) Claim depth 11.0 pts (22%)

Qualcomm Incorporated · highest

85
Aposense · this assignee

51
3D Lighting… · lowest

7

What this shows Aposense's Innovation Score is 50.7/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Aposense?

Each dot is one of Aposense’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aposense’s own 18.3 claims/patent is at or below the 18.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Aposense vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aposense's grants concentrate

Aposense Ltd is a focused PatentsView assignee: 11 CPC subclasses with 88.9% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2015. By volume, Aposense sits between AOK Innovations, LLC and Apttex Corporation.

Aposense's three-year grant acceleration

Aposense Ltd shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

AOK Innovations

9
Aperture Investme…

9
APEX AI

9
API Market

9
Appnomic Systems…

9
APR Applied Pharm…

9
Aptera Motors

9
Apttex

9
Aposense ◀

9

What this shows Aposense holds 9 patents at rank #28,025, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aposense

By rank, the assignees closest to #28,025 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Aposense's primary technology class.

Aposense's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 13% higher than 87% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Aposense Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	11.1%
2017	1	11.1%
2018	2	22.2%
2019	1	11.1%
2022	3	33.3%
2025partial year	1	11.1%

Which technologies does Aposense Ltd patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

C07J - Steroids 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

C12Y - Enzymes 2

C07D - Heterocyclic Compounds 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C07C - Acyclic OR Carbocyclic Compounds 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Aposense Ltd's patent record in context - here's where to go next.

Aposense Ltd's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 88.9% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #28,096 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aposense Ltd against AOK Innovations, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.